| EPE0891 | Economic evaluation of HIV infection recency at four health facilities in Bangkok, Thailand | E-poster | Costing, cost effectiveness and affordability |
| EPE0896 | Economic assessment and evaluation of Medically Assisted Therapy (MAT) services in six counties in Kenya | E-poster | Costing, cost effectiveness and affordability |
| EPE0896 | Economic assessment and evaluation of Medically Assisted Therapy (MAT) services in six counties in Kenya | E-poster | Costing, cost effectiveness and affordability |
| EPB0172 | Early outcomes of successful integration of mental health screening into routine HIV care in Malawi | E-poster | Co-morbidities |
| EPA0029 | Early initiation of anti-retroviral therapy restores some but not all perturbations of natural killer cell functions and phenotypes in early HIV-1 infected men who have sex with men | E-poster | Host immune responses, vaccines and immunotherapies |
| EPE0858 | Early effect of transitioning children to dolutegravir-based regimens on viral load suppression in Malawi | E-poster | Implementation science and scale up of treatment |
| MOPEB07 | Early clinical experience using tecovirimat during the Mpox epidemic in Toronto suggests ongoing clinical equipoise for randomized trials | Poster exhibition | Co-infections (including opportunistic infections) |
| EPB0249 | Early ART and mental health outcomes by school-age and adolescent years of life: a longitudinal comparative study of HIV-exposed and community control adolescents from Uganda | E-poster | Antiretroviral therapies and clinical issues in infants, children and adolescents |
| EPA0012 | Dysregulated transcriptional signature of Th17-Polarized cells during chronic HIV Infection despite successful antiretroviral therapy compared to uninfected individuals | E-poster | HIV pathogenesis |
| EPB0136 | Dynamics of cellular senescence markers after HCV elimination spontaneously or by DAAs in people living with HIV | E-poster | Co-infections (including opportunistic infections) |